Component: (Network and Table) | |
---|---|
Network | 00400 - Statement - Consolidated Statements of Cash Flows (http://www.2u.com/role/StatementConsolidatedStatementsOfCashFlows) |
Table | (Implied) |
Reporting Entity [Axis] | 0001459417 (http://www.sec.gov/CIK) |
Consolidated Statements of Cash Flows | Period [Axis] | ||
---|---|---|---|
2016-01-01 - 2016-12-31 | 2015-01-01 - 2015-12-31 | 2014-01-01 - 2014-12-31 | |
Consolidated Statements of Cash Flows | |||
Cash flows from operating activities | |||
Net loss | (20,684,000) | (26,733,000) | (28,999,000) |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||
Depreciation and amortization | |||
Stock-based compensation expense | |||
Charge related to execution of new lease agreement | |||
Changes in operating assets and liabilities: | |||
(Increase) decrease in accounts receivable, net | ( | ( | |
Increase in advances to clients | ( | ( | ( |
Increase in prepaid expenses and other current assets | ( | ( | ( |
(Decrease) increase in accounts payable | ( | ( | |
Increase in accrued compensation and related benefits | |||
Increase in accrued expenses and other liabilities | |||
Increase in deferred revenue | |||
Decrease (increase) in payments to clients | ( | ( | |
Decrease (increase) in other assets and other liabilities, net | ( | ||
Other | |||
Net cash provided by (used in) operating activities | ( | ( | |
Cash flows from investing activities | |||
Capitalized technology and content development cost expenditures | ( | ( | ( |
Purchases of property and equipment | ( | ( | ( |
Other | ( | ( | ( |
Net cash used in investing activities | ( | ( | ( |
Cash flows from financing activities | |||
Proceeds from exercise of stock options | |||
Proceeds from issuance of common stock, net of offering costs | |||
Proceeds from revolving line of credit | |||
Payment on revolving line of credit | ( | ||
Other | ( | ( | |
Net cash provided by financing activities | |||
Net (decrease) increase in cash and cash equivalents | ( | ||
Cash and cash equivalents, beginning of period | 183,729,000 | ||
Cash and cash equivalents, end of period | 168,730,000 | 183,729,000 | 86,929,000 |
Supplemental disclosure of non-cash investing and financing activities | |||
Accrued capital expenditures | |||
Accretion of issuance costs on redeemable convertible preferred stock | 89,000 | ||
Common stock granted in exchange for consulting services received |